{"id":169037,"date":"2024-04-09T13:01:11","date_gmt":"2024-04-09T17:01:11","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/scilex-holding-company-announces-launching-of-co-pay-programs-for-both-ztlido-and-elyxyb-for-commercially-insured-patients-and-the-addition-of\/"},"modified":"2024-08-18T11:48:08","modified_gmt":"2024-08-18T15:48:08","slug":"scilex-holding-company-announces-launching-of-co-pay-programs-for-both-ztlido-and-elyxyb-for-commercially-insured-patients-and-the-addition-of","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/scilex-holding-company-announces-launching-of-co-pay-programs-for-both-ztlido-and-elyxyb-for-commercially-insured-patients-and-the-addition-of.php","title":{"rendered":"Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido\u00ae and ELYXYB\u00ae for Commercially Insured Patients and the addition of&#8230;"},"content":{"rendered":"<p><![CDATA[PALO ALTO, Calif., April  09, 2024  (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, \u201cScilex\u201d or \u201cCompany\u201d), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced launching of co-pay programs for both ZTlido\u00ae and ELYXYB\u00ae with the out-of-pocket costs for its product portfolio for commercially insured patients capped at $25 monthly, with certain eligible patients paying as low as $0. This applies to the Company's postherpetic neuralgia pain product, ZTlido\u00ae, and migraine product, ELYXYB\u00ae. Scilex has made significant investments to improve patient affordability and access to its products and continues to build on the Company's commitment to provide non-opioid pain management products to patients.]]><\/p>\n<p>Read more here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2024\/04\/09\/2860032\/0\/en\/Scilex-Holding-Company-Announces-Launching-of-Co-Pay-Programs-for-Both-ZTlido-and-ELYXYB-for-Commercially-Insured-Patients-and-the-addition-of-ELYXYB-to-a-Multi-State-Medicaid-Phar.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido\u00ae and ELYXYB\u00ae for Commercially Insured Patients and the addition of...\">Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido\u00ae and ELYXYB\u00ae for Commercially Insured Patients and the addition of...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more here: Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido\u00ae and ELYXYB\u00ae for Commercially Insured Patients and the addition of... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/scilex-holding-company-announces-launching-of-co-pay-programs-for-both-ztlido-and-elyxyb-for-commercially-insured-patients-and-the-addition-of.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-169037","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169037"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=169037"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/169037\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=169037"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=169037"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=169037"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}